Connect with us

Health

Senior care homes, restaurants fined for breaking Manitoba Health coronavirus rules – Globalnews.ca

Published

on


A total of 10 fines have been handed out to businesses for breaking Manitoba Health protocols since the COVID-19 pandemic hit the province.

The list includes restaurants, spas and senior care businesses.


READ MORE:
Coronavirus: Flouting public health rules will now bring $486 fine for Manitobans

The latest infractions occurred at private home care business, Daughter on Call.

The company was hit with two separate fines totaling $5,084.

The first fine was at their Brandon location on May 15.

The province says the fine was for failing “to comply with a public emergency health order, namely direction given to take immediate and adequate precautions to control or minimize the risk of transmission of a communicable disease.”

Story continues below advertisement

The second fine against Daughter on Call was at their Carberry location, nearly one week later on May 21.

This time the province says the fine was for failing “to comply with a public emergency health order, namely May 14, 2020 Medical Officer of Health health hazard order.”

[ Sign up for our Health IQ newsletter for the latest coronavirus updates ]

Global News has reached out to Daughter on Call for comment.


READ MORE:
Body rub parlour, salon latest to be fined by Manitoba Public Health

Other businesses on the list of violations for not following Public Health orders include:

Joey’s Only Seafood Restaurant located at 1615 Regent Ave. West in Winnipeg with a fine of $2,542.

Massage parlour Executive Bath located at 835 Ellice Ave. in Winnipeg was given a $2,542 fine.

Sung’s Restaurant located at 104 Main St. North in Dauphin was given a fine of $486.






1:11
Disobeying health orders land some Manitoba businesses with fines


Disobeying health orders land some Manitoba businesses with fines

Beauty Infinity 2 located at 1700 Corydon Ave. in Winnipeg was given a fine of $2,542.

Thi Bui located at 647 Union Ave. E in Winnipeg was given a fine of $486.

JT’S Club 10 at 1030 Keewatin St. in Winnipeg was fined $2,542.

Story continues below advertisement

California Nails at 1372 McPhillips St. in Winnipeg was fined $486.

Ruby Nail Bar at 200 – 855 Regent Ave. W in Winnipeg was fined $486.

© 2020 Global News, a division of Corus Entertainment Inc.

Let’s block ads! (Why?)



Source link

Continue Reading

Health

Public health working to contain latest COVID-19 outbreaks – WellandTribune.ca

Published

on




Public health working to contain latest COVID-19 outbreaks | WellandTribune.ca


Top Stories

Top Stories


Let’s block ads! (Why?)



Source link

Continue Reading

Health

'No benefit' from hydroxychloroquine for virus: UK trial – The Jakarta Post – Jakarta Post

Published

on


A major British clinical trial has found hydroxychloroquine has “no benefit” for patients hospitalized with COVID-19, scientists said Friday, in the first large-scale study to provide results for a drug at the center of political and scientific controversy.     

Hydroxychloroquine, a decades-old malaria and rheumatoid arthritis drug, has been touted as a possible treatment for the new coronavirus by high profile figures, including US President Donald Trump, and has been included in several randomized clinical trials.

The University of Oxford’s Recovery trial, the biggest of these so far to come forward with findings, said that it would now stop recruiting patients to be given hydroxychloroquine “with immediate effect”.

“Our conclusion is that this treatment does not reduce the risk of dying from COVID among hospital patients and that clearly has a significant importance for the way patients are treated, not only in the UK, but all around the world,” said Martin Landray, an Oxford professor of medicine and epidemiology who co-leads the study.

The randomized clinical trial—considered the gold standard for clinical investigation—has recruited a total of 11,000 patients from 175 hospitals in the UK to test a range of potential treatments.

Other drugs continuing to be tested include: the combination of HIV antivirals Lopinavir and Ritonavir; a low dose of the steroid Dexamethasone, typically used to reduce inflammation; antibiotic Azithromycin; and the anti inflammatory drug Tocilizumab.

Researchers are also testing convalescent plasma from the blood of people who have recovered from COVID-19, which contains antibodies to fight the virus.

Researchers said 1,542 patients were randomly assigned to hydroxychloroquine and compared with 3,132 patients given standard hospital care alone.

They found “no significant difference” in mortality after 28 days between the two groups, and no evidence that treatment with the drug shortens the amount of time spent in hospital.

“This is a really important result, at last providing unequivocal evidence that hydroxychloroquine is of no value in treatment of patients hospitalized with COVID-19,” said Peter Openshaw, a professor at Imperial College London, in reaction to the results.

He added that the drug was “quite toxic” so halting the trials would be of benefit to patients. 

Hydroxychloroquine has been in use for years but it has a number of potentially serious side effects, including heart arrhythmia.

Researchers from the Recovery trial said they would share their data with the World Health Organization (WHO), which on Wednesday restarted its own trials of hydroxychloroquine.

They were temporarily halted last month because of a now-retracted observational study in The Lancet medical journal that had suggested hydroxychloroquine and chloroquine, a related compound, were ineffective against COVID-19 and even increased the risk of death.

Authors of The Lancet research said on Thursday that they could no longer vouch for the integrity of its underlying data, in the face of serious concerns raised by fellow scientists over a lack of clarity about the countries and hospitals that contributed patient information.  

The scandal cast a shadow over The Lancet and another top medical journal, but it did nothing to clear up the increasingly politicized question of whether or not hydroxychloroquine works as a treatment for COVID-19.

Openshaw said the Recovery trial should be credited with continuing the research until they could reach a definitive conclusion on hydroxychloroquine.

“Everyone regrets that it doesn’t work, but knowing that allows us to focus on finding drugs that actually help recovery from COVID-19,” he added.

Oxford professor Peter Horby, the lead investigator on the Recovery Trial, said there was probably a “very large number” of people around the world taking hydroxychloroquine for COVID-19, with countries including the US, China and Brazil authorizing it.

A separate clinical trial on Wednesday in the US and Canada found that taking hydroxychloroquine shortly after being exposed to COVID-19 does not work to prevent infection significantly better than a placebo.

If you want to help in the fight against COVID-19, we have compiled an up-to-date list of community initiatives designed to aid medical workers and low-income people in this article. Link: [UPDATED] Anti-COVID-19 initiatives: Helping Indonesia fight the outbreak
 

Let’s block ads! (Why?)



Source link

Continue Reading

Health

No new coronavirus cases in Manitoba on Saturday – Globalnews.ca

Published

on


Manitoba health officials say there are no new cases of the coronavirus identified as of Saturday morning.

Health officials say the total number of lab-confirmed positive and probable cases in the province remains at 300.

There are nine active cases as of Friday and 284 individuals who have recovered from COVID-19.

The number of deaths due to COVID-19 remains at seven.

Story continues below advertisement

© 2020 Global News, a division of Corus Entertainment Inc.

Let’s block ads! (Why?)



Source link

Continue Reading

Trending